Search
for
Sort by
Research 181–210 of 185
- Integrating Ayush practitioners in outbreak investigations in India: a call for action
- Wnt/β-Catenin Signaling Pathway Targeting Androgenetic Alopecia: How Far Can We Go Beyond Minoxidil and Finasteride?
- Cell regeneration in the therapy of androgenic alopecia
- Trichoscopic Hallmarks in Non-cicatricial and Cicatricial Alopecia in Indian Population: A Narrative Review
- IN SILICO STUDY OF 12 PHYTOSTEROL COMPOUNDS IN MORINGA (MORINGA OLEIFERA LAMK.) SEED OIL ON 5Α-REDUCTASE ENZYME INHIBITION ACTIVITY AS ANTI-ALOPECIA
- Dengue-associated telogen effluvium: A report of 14 patients
- Dengue-Associated Telogen Effluvium Causing Body Dysmorphic Disorder
- Low Platelet Count and Hematocrit as Risk Factors for Alopecia in Dengue Fever: A Retrospective Analysis
- Telogen effluvium as first clinical presentation of dengue
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Queda de cabelo pós – dengue
- Skin manifestations associated with COVID-19
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
- Trichodynia Revisited
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Unraveling the psychological impact of telogen effluvium: Understanding hair loss beyond the scalp
- CARACTERÍSTICAS CLÍNICAS E EPIDEMIOLÓGICAS DO EFLÚVIO TELÓGENO PÓS COVID-19
- Covid induced telogen effluvium (CITE): An insight
- COVID-19 infection is a major cause of acute telogen effluvium
- Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
- FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
- Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
- Telogen Effluvium – a review of the science and current obstacles
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Telogen Effluvium in Patients recovering from COVID-19
- Acute Telogen Effluvium: A Post-COVID-19 Sequela
- Telogen Effluvium After COVID-19 Infection: A Case Report
- Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents